FB

Frank Borriello

Scientific Founder, MD, PhD

Alloplex Biotherapeutics

Therapeutic Areas

Alloplex Biotherapeutics Pipeline

DrugIndicationPhase
SUPLEXAMetastatic Solid Tumors (broad)Phase 2
ENLIST Platform (Allogeneic)Oncology / AutoimmunityPreclinical